132 related articles for article (PubMed ID: 36652867)
1. Automated warfarin dose prediction for Asian, American, and Caucasian populations using a deep neural network.
Jahmunah V; Chen S; Oh SL; Acharya UR; Chowbay B
Comput Biol Med; 2023 Feb; 153():106548. PubMed ID: 36652867
[TBL] [Abstract][Full Text] [Related]
2. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
[TBL] [Abstract][Full Text] [Related]
3. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
[TBL] [Abstract][Full Text] [Related]
4. Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients.
Sasano M; Ohno M; Fukuda Y; Nonen S; Hirobe S; Maeda S; Miwa Y; Yokoyama J; Nakayama H; Miyagawa S; Sawa Y; Fujio Y; Maeda M
Eur J Clin Pharmacol; 2019 Jul; 75(7):901-911. PubMed ID: 30852642
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Maintenance Dose Predictions by Warfarin Dosing Algorithms Based on Chinese and Western Patients.
Deng J; Wang Y; An X
J Clin Pharmacol; 2023 May; 63(5):569-582. PubMed ID: 36546564
[TBL] [Abstract][Full Text] [Related]
6. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
[TBL] [Abstract][Full Text] [Related]
7. Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose.
Ma Z; Wang P; Gao Z; Wang R; Khalighi K
PLoS One; 2018; 13(10):e0205872. PubMed ID: 30339708
[TBL] [Abstract][Full Text] [Related]
8. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population.
Chumnumwat S; Yi K; Lucksiri A; Nosoongnoen W; Chindavijak B; Chulavatnatol S; Sarapakdi A; Nathisuwan S
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29243335
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of Warfarin in a Diverse Patient Population.
Mak M; Lam C; Pineda SJ; Lou M; Xu LY; Meeks C; Lin C; Stone R; Rodgers K; Mitani G
J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):521-533. PubMed ID: 31064211
[TBL] [Abstract][Full Text] [Related]
10. DBCSMOTE: a clustering-based oversampling technique for data-imbalanced warfarin dose prediction.
Tao Y; Zhang Y; Jiang B
BMC Med Genomics; 2020 Oct; 13(Suppl 10):152. PubMed ID: 33087117
[TBL] [Abstract][Full Text] [Related]
11. VKORC1 and CYP2C9 genotypic data-based dose prediction alone does not accurately predict warfarin dose requirements in some Malaysian patients.
Chua YA; Abdullah WZ; Yusof Z; Gan SH
Turk J Med Sci; 2015; 45(4):913-8. PubMed ID: 26422867
[TBL] [Abstract][Full Text] [Related]
12. Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.
Hernandez W; Gamazon ER; Aquino-Michaels K; Patel S; O'Brien TJ; Harralson AF; Kittles RA; Barbour A; Tuck M; McIntosh SD; Douglas JN; Nicolae D; Cavallari LH; Perera MA
Pharmacogenomics J; 2014 Jun; 14(3):223-8. PubMed ID: 24018621
[TBL] [Abstract][Full Text] [Related]
13. CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
Scott SA; Jaremko M; Lubitz SA; Kornreich R; Halperin JL; Desnick RJ
Pharmacogenomics; 2009 Aug; 10(8):1243-55. PubMed ID: 19663669
[TBL] [Abstract][Full Text] [Related]
14. A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional.
Sridharan K; Sivaramakrishnan G
J Clin Pharm Ther; 2021 Jun; 46(3):640-648. PubMed ID: 33346393
[TBL] [Abstract][Full Text] [Related]
15. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
Schwartz JB; Kane L; Moore K; Wu AH
J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
[TBL] [Abstract][Full Text] [Related]
16. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
[TBL] [Abstract][Full Text] [Related]
17. Validation of warfarin pharmacogenetic algorithms in 586 Han Chinese patients.
Peng Q; Huang S; Chen X; Yuan Y; Yu Y; Tao L; Zhang Z; Xu M
Pharmacogenomics; 2015; 16(13):1465-74. PubMed ID: 26255607
[TBL] [Abstract][Full Text] [Related]
18. [Verification of accuracy of warfarin stable dose prediction models in Shandong population].
Ge Y; Qu F; Wang S; Guo X; Wang C; Liu S; Ma A; Jiang X; Tan K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Apr; 37(4):401-404. PubMed ID: 32219822
[TBL] [Abstract][Full Text] [Related]
19. Performance Evaluation of Warfarin Dose Prediction Algorithms and Effects of Clinical Factors on Warfarin Dose in Chinese Patients.
Gao W; Li Z; Chen W; Zhang S
Ther Drug Monit; 2021 Aug; 43(4):527-535. PubMed ID: 34250965
[TBL] [Abstract][Full Text] [Related]
20. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
Pathare A; Al Khabori M; Alkindi S; Al Zadjali S; Misquith R; Khan H; Lapoumeroulie C; Paldi A; Krishnamoorthy R
J Hum Genet; 2012 Oct; 57(10):665-9. PubMed ID: 22854539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
